All In Biotech

Free tool

FAERS Monitor: Baraclude

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021798 or its brand name (Baraclude, Entecavir). Reports on generic versions are filed under their own applications.

Reports

11,801

Serious

10,278

87% of reports

Hospitalization

4,532

Death reported

1,893

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death554
  • off label use553
  • drug ineffective451
  • drug resistance407
  • diarrhoea389
  • pyrexia372
  • fatigue369
  • hepatitis b332
  • nausea328
  • pneumonia309
  • platelet count decreased302
  • anaemia238
  • renal impairment236
  • hepatic failure233
  • neutropenia229

Reports by year received

View as table
YearReports
20042
200515
200664
2007193
2008160
2009234
2010308
2011317
2012433
2013378
2014654
2015652
2016823
2017761
2018787
2019858
2020740
2021758
2022793
2023783
2024796
2025755
2026537

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,358 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hepatitis bSignal332103.993.131,870
drug resistanceSignal40728.726.010,686
hepatic failureSignal23313.912.22,753
platelet count decreasedSignal3025.14.5982
renal impairmentSignal2365.04.4756
neutropeniaSignal2293.02.6306
anaemiaSignal2382.22.0161
pyrexia3721.91.7165
pneumonia3091.71.590
death5541.11.111
off label use5531.11.08
diarrhoea3891.11.02
fatigue3690.80.811
nausea3280.70.731
drug ineffective4510.60.6120

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.